Evidence map›Paper›PMID 35896506›Full record

Trial reportApplied clinical informatics2022

Evaluating the Effect of a COVID-19 Predictive Model to Facilitate Discharge: A Randomized Controlled Trial.

Vincent J Major, Simon A Jones, Narges Razavian, Ashley Bagheri, Felicia Mendoza, Jay Stadelman, Leora I Horwitz, Jonathan Austrian, Yindalon Aphinyanaphongs

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Applied clinical informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04570488 (Predicting Favorable Outcomes in Hospitalized Covid-19 Patients), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04570488 completednot on this map

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

TypeobservationalSponsorNYU Langone HealthRan2020 to 2021Enrolled1,415ConditionsCOVID, Corona Virus Infection, Adverse EventArmsEPIC risk score display
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Vincent J MajorCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Simon A JonesCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Narges RazavianCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Ashley BagheriCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Felicia MendozaCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Jay StadelmanCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Leora I HorwitzCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Jonathan AustrianDepartment of Medicine, NYU Grossman School of Medicine, New York, New York, United States.
Yindalon AphinyanaphongsCenter for Healthcare Innovation & Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States.
Center for Innovation · USNew York University · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
NCATS NIH HHS UL1 TR001445NIA NIH HHS P30 AG066512
6 · The paper itself

Abstract

backgroundWe previously developed and validated a predictive model to help clinicians identify hospitalized adults with coronavirus disease 2019 (COVID-19) who may be ready for discharge given their low risk of adverse events. Whether this algorithm can prompt more timely discharge for stable patients in practice is unknown.

objectivesThe aim of the study is to estimate the effect of displaying risk scores on length of stay (LOS).

methodsWe integrated model output into the electronic health record (EHR) at four hospitals in one health system by displaying a green/orange/red score indicating low/moderate/high-risk in a patient list column and a larger COVID-19 summary report visible for each patient. Display of the score was pseudo-randomized 1:1 into intervention and control arms using a patient identifier passed to the model execution code. Intervention effect was assessed by comparing LOS between intervention and control groups. Adverse safety outcomes of death, hospice, and re-presentation were tested separately and as a composite indicator. We tracked adoption and sustained use through daily counts of score displays.

resultsEnrolling 1,010 patients from May 15, 2020 to December 7, 2020, the trial found no detectable difference in LOS. The intervention had no impact on safety indicators of death, hospice or re-presentation after discharge. The scores were displayed consistently throughout the study period but the study lacks a causally linked process measure of provider actions based on the score. Secondary analysis revealed complex dynamics in LOS temporally, by primary symptom, and hospital location.

conclusionAn AI-based COVID-19 risk score displayed passively to clinicians during routine care of hospitalized adults with COVID-19 was safe but had no detectable impact on LOS. Health technology challenges such as insufficient adoption, nonuniform use, and provider trust compounded with temporal factors of the COVID-19 pandemic may have contributed to the null result.

trial registrationClinicalTrials.gov identifier: NCT04570488.

Indexed as

COVID-19AdultHospitalizationHumansPandemicsPatient DischargeSARS-CoV-2Treatment Outcome

Identifiers

PMID35896506
PMCPMC9329139
OpenAlexW4288070788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.